Literature DB >> 7691587

Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells.

C M Silva1, R N Day, M J Weber, M O Thorner.   

Abstract

Activation of the GH receptor (GHR) results in tyrosine phosphorylation of cellular proteins, and this tyrosine phosphorylation is believed to be important in GH action. We have shown previously that GH rapidly stimulates the tyrosine phosphorylation of 134-, 120-, and 93-kilodalton (kDa) proteins in the human IM-9 lymphocyte line. We now provide three lines of evidence indicating that the 134-kDa tyrosine-phosphorylated protein, not the 120- or 93-kDa proteins, is the GHR. 1) A monoclonal antibody that interacts with the extracellular domain of the GHR (Mab263) immunoprecipitated a 134-kDa phosphotyrosine-containing protein, but not a 120- or 93-kDa protein, from GH-treated IM-9 cells. 2) The GHR contains N-linked carbohydrates. When total cell lysates from GH-treated IM-9 cells were treated with endoglycosidases to remove these carbohydrates, the majority of the 134-kDa phosphotyrosine-containing protein was no longer detected. Furthermore, the immunoprecipitated 134-kDa protein was completely deglycosylated and resulted in a single band of approximately 100 kDa. Neither the 120- nor 93-kDa tyrosine-phosphorylated proteins were affected by endoglycosidase treatment. 3) The Mab263 antibody immunoprecipitated a 134-kDa phosphotyrosine-containing protein from GH-treated 293 cells (human embryonic kidney cell line) that stably express the full-length rabbit GHR. This protein was not detected in control cells expressing the neomycin resistance gene alone. We conclude that the 134-kDa protein that is tyrosine phosphorylated upon GH stimulation of IM-9 cells is the GHR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691587     DOI: 10.1210/endo.133.5.7691587

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes.

Authors:  Vandana Singhal; Brian C Goh; Mary L Bouxsein; Marie-Claude Faugere; Douglas J DiGirolamo
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

2.  Nuclear factor-kappaB (NF-kappaB) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2.

Authors:  Shufang Wu; Allison Morrison; Hongzhi Sun; Francesco De Luca
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

Review 3.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

4.  Small molecules to regulate the GH/IGF1 axis by inhibiting the growth hormone receptor synthesis.

Authors:  Lieke M van der Velden; Peter Maas; Miranda van Amersfoort; Elpetra P M Timmermans-Sprang; Anneloes Mensinga; Elisabeth van der Vaart; Fabrice Malergue; Henk Viëtor; Patrick W B Derksen; Judith Klumperman; Andreas van Agthoven; David A Egan; Jan A Mol; Ger J Strous
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.